Fahrni Jennifer, Engelberger Rolf Peter, Kucher Nils, Willenberg Torsten, Baumgartner Iris
Department for Angiology, Inselspital, Bern University Hospital, Bern, Switzerland.
Vasa. 2013 May;42(3):161-7. doi: 10.1024/0301-1526/a000264.
Ilio-femoral deep vein thrombosis (DVT) has a high rate of long-term morbidity in the form of the postthrombotic syndrome (PTS). Therefore, management of acute thrombosis should not only focus on the prevention of acute complications such as propagation or embolisation of the initial clot but also on preventing PTS and recurrent thrombosis. Contemporary catheter-based treatments of deep vein thrombosis have proven to be safe and effective in selected patients. Current guidelines recommend medical therapy with anticoagulation alone for all but the most severe, limb-threatening thrombosis. They additionally allow for consideration of catheter-based treatment in patients with acute DVT and low risk of bleeding complications to prevent PTS. Recent studies favoring interventional therapy have not been included in these guidelines. Data on long-term outcome is expected to be published soon, clarifying and very likely strengthening the role of catheter-based treatments in the management of acute ilio-femoral DVT.
髂股深静脉血栓形成(DVT)会以血栓形成后综合征(PTS)的形式导致较高的长期发病率。因此,急性血栓的管理不仅应侧重于预防急性并发症,如初始血栓的蔓延或栓塞,还应预防PTS和复发性血栓形成。当代基于导管的深静脉血栓治疗方法已被证明在特定患者中是安全有效的。目前的指南建议,除了最严重的、危及肢体的血栓形成外,所有患者均单独采用抗凝药物进行药物治疗。指南还允许考虑对急性DVT且出血并发症风险较低的患者采用基于导管的治疗方法,以预防PTS。近期支持介入治疗的研究尚未纳入这些指南。关于长期结果的数据预计很快会公布,这将阐明并很可能加强基于导管的治疗方法在急性髂股DVT管理中的作用。